Answer a few questions and see if you or your child may be eligible.
The purpose of this study is to evaluate the efficacy and safety of the investigational study medication in adults (18-75 years old) and adolescents (12-17 years old) with moderate to severe Atopic Dermatitis, also known as Eczema. The study medication is a tablet and will be taken by mouth.
You (or your child) may qualify for this research study, if the following applies to you (or your child):
There are other eligibility requirements. A final decision on whether this research study might be suitable for you/your child will be made after you speak with the study doctor at the research site. The study doctor will explain the benefits and risks of participation in this research study.
You may receive reimbursement for your time and travel expenses related to study participation.
Registering for this and any future study via ClinLife is free and non-binding:
Taking part in any clinical study is voluntary. You have the right to leave a clinical study at any time, for any reason.
Once you’ve successfully completed the online questionnaire, you can to select a study center near you.
After you’ve submitted your contact details, a representative from the study center or a ClinLife Call Center Agent will be in contact with you within the next few days.
They will ask you additional questions and answer any questions you may have. The benefits and risks will be explained to you and you will also receive information on the possible allowance.
If the study center staff determines that the study is suitable for you or your child, they will schedule an appointment with you.
If the study you are interested in is not suitable for you or your child, we can keep you informed about upcoming studies that might be better suited for you.
ClinLife is a free and easy-to-use website helping patients worldwide find the most relevant clinical studies suitable to their medical condition. Listing all available studies by disease area or medical condition, it provides an essential link between research sites and people seeking clinical research studies.